Figure 5

Hep-G2 cells were treated with cisplatin (10 μM), 1 (8 μM), 2 (15 μM), 3 (5 μM), 4 (18 μM), 5 (28 μM) and 6 (14 μM) at 37 °C for 24 h, respectively.
Hep-G2 cells were treated with cisplatin (10 μM), 1 (8 μM), 2 (15 μM), 3 (5 μM), 4 (18 μM), 5 (28 μM) and 6 (14 μM) at 37 °C for 24 h, respectively.